INNT
TOTAL INVALIDATION PROCESSED BY THE IB
26/02/2026
Voltar para busca
Dado oficial do USPTO
ONCOBAX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ONCOBAX
ST13
US500000079214556Classe
5, 9, 10, 42, 44
Pedido
79214556
Registro
5483194
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
27/02/2026
Tipo de marca
Verbal
Classes Nice
5, 9, 10, 42, 44
Data de depósito
29/05/2017
Data de registro
05/06/2018
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/12/2024
Última transação
27/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
FR
Examinador
VAGHANI, MAYUR C
Unidade examinadora
N60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
EVERIMMUNE
G. T. (pessoa física)
Representantes
Bruce S. Londa Norris McLaughlin P.A.
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical productspharmaceutical preparations for the prevention and treatment of cancermedicines for the prevention and treatment of cancer and vaccines for treatment and prevention of cancer
Classe 9
Computer programs for aiding in the detectionrecognitionevaluationdiagnosis and characterization of cancerfor aiding for the treatment and prevention of cancerfor searching for similar cases in databases or archiving systemsfor generating analytical or diagnostic reports; software for aiding in the detectionrecognitionevaluationdiagnosis and characterization of cancerfor aiding for the treatment and prevention of cancerfor searching for similar cases in databases or archiving systemsfor generating analytical or diagnostic reports; recorded computer programs regardless of the medium for aiding in the detectionrecognitionevaluationdiagnosis and characterization of cancerfor aiding for the treatment and prevention of cancerfor searching for similar cases in databases or archiving systemsfor generating analytical or diagnostic reports; magneticelectronicopticalmagneto-optical data mediablank magneticelectronicopticalmagneto-optical data media and prerecorded magneticelectronicopticalmagneto-optical data media featuring information on cancermemory cardsCD-ROMsblank CD-ROM's for recording and prerecorded CD-ROMs featuring information on cancerdigital video disksblank digital video disks and prerecorded digital video disks featuring information on cancer; optical disksblank optical disks and pre-recorded optical disks featuring information on cancer; magneto-optical disksblank magneto-optical disks and prerecorded magneto optical disksfeaturing information on cancer; magnetic tapesblank magnetic tapes and prerecorded magnetic tapesfeaturing information on cancer; downloadable software for aiding in the detectionrecognitionevaluationdiagnosis and characterization of cancerfor aiding for the treatment and prevention of cancerfor searching for similar cases in databases or archiving systemsfor generating analytical or diagnostic reports; computer programs and software used for the acquisitionvisualizationprocessingexploitationannotationstoragesearchingdissemination and printing of all types of medical dataespecially of images obtained by a radio-graphic meansby X-rayscannerpet scanultrasonographymagnetic resonancetomography for the purpose of cancer screeningdiagnosis or treatmentin the medicalsurgical and health field and in cancer research; scientificphotographiccinematographicopticalmeasuring apparatus and instrumentscomputersmicroscopes; apparatus for recording transmission and reproduction of sound or images; equipment for processing informationdata processing equipmentcomputers
Classe 10
Surgical apparatus and instruments; medicaldental and veterinary apparatus and instrumentsx-ray apparatusscannerpositron emission tomography (PET) scannersmagnetic resonance imaging scannerultrasound scannerradiotherapy treatment apparatusartificial limbseyes and teeth; orthopedic articlesartificial orthopedic implantsorthopedic bandages and splintsorthopedic braces; suture material
Classe 42
Scientific research services for medical purposes in the area of cancer researchmedical research servicesresearch and development of new medical products; research in the fields of bacteriologybiologychemistryinformation services in the field of medical research in the fight against cancer; clinical research in the area of cancer researchmedical research and biology medical laboratories; scientificpharmaceuticalmedical and clinical research for new treatments and pharmaceutical productsvaccinesmedicines against cancer
Classe 44
Medical services; hospital services; medical analysesmedical analysis and testing for diagnostic or treatment purposes in the area of cancer; medical expertise servicesmedical diagnostic testingmonitoringreporting and performing a diagnosis of cancer; health servicestreatment of cancer; medical and surgical servicesmedical diagnostic testingmonitoringreporting and performing a diagnosis of cancersurgical treatment of cancer; medical imagingradiotherapybrachytherapy and medical dosimetry services for treating cancer; medical diagnosis servicesanalysis and interpretation of images generated by x-ray apparatusscannerpositron emission tomography (PET) scannersmagnetic resonance imaging scannerultrasound scanner; information services in the field of the fight against cancerinformation on cancer treatment
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
10/02/2026
INPC
INVALIDATION PROCESSED
09/02/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
20/08/2025
C71T
CANCELLED SECTION 71
20/12/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
13/04/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/06/2023
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
16/08/2022
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
04/07/2022
CHLD
CHANGE OF OWNER RECEIVED FROM IB
22/05/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/02/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
23/01/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/10/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
17/09/2018
FIMP
FINAL DISPOSITION PROCESSED
17/09/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/09/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
05/06/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/03/2018
PUBO
PUBLISHED FOR OPPOSITION
20/03/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/02/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/02/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
14/02/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
14/02/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
14/02/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
14/02/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/01/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/01/2018
ALIE
ASSIGNED TO LIE
25/01/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/01/2018
RFNT
REFUSAL PROCESSED BY IB
22/09/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/09/2017
RFRR
REFUSAL PROCESSED BY MPU
02/09/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
31/08/2017
CNRT
NON-FINAL ACTION WRITTEN
30/08/2017
DOCK
ASSIGNED TO EXAMINER
28/08/2017
MAFR
APPLICATION FILING RECEIPT MAILED
25/08/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/08/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
17/08/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ONCOBAX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.